Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data

  • News
  • Press Releases
  • Research
  • Business
  • Regulatory
  • Events and Conferences
The Pharma Data
  • Regulatory

Teva and Alvotech Receive FDA Approval for SELARSDI™ as an Interchangeable Biosimilar to Stelara

  • The Pharma Data
  • May 6, 2025

Teva and Alvotech Expand U.S. Biosimilar Portfolio with Approval for SELARSDI™ Teva Pharmaceuticals, the U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Alvotech (NASDAQ: ALVO) have…

Read MoreTeva and Alvotech Receive FDA Approval for SELARSDI™ as an Interchangeable Biosimilar to Stelara
  • News

WHO Reminds Us: Gloves Are No Replace for Hand Hygiene

  • The Pharma Data
  • May 6, 2025

WHO Highlights the Importance of Hand Hygiene Over Gloves on World Hand Hygiene Day Hand hygiene remains one of the most effective, affordable, and universal tools in preventing the spread…

Read MoreWHO Reminds Us: Gloves Are No Replace for Hand Hygiene
  • News

Johnson & Johnson Unveils Oncology Care Index, Exposing Gaps Between Cancer Innovation and Real-World Practice

  • The Pharma Data
  • May 6, 2025

73% of healthcare professionals (HCPs) report a disconnect between the availability of cutting-edge treatments and their effective implementation in clinical practice, while 3 in 4 oncologists say the rapid pace…

Read MoreJohnson & Johnson Unveils Oncology Care Index, Exposing Gaps Between Cancer Innovation and Real-World Practice
  • Research

TREMFYA® Sustains Remission in Ulcerative Colitis Through Two Years

  • The Pharma Data
  • May 6, 2025

TREMFYA® Shows Sustained Long-Term Remission in Ulcerative Colitis Patients, According to Phase 3 QUASAR LTE Study More than 70% of patients in clinical remission and over 40% in endoscopic remission…

Read MoreTREMFYA® Sustains Remission in Ulcerative Colitis Through Two Years
GSK advances the future of respiratory medicine and patient care with new data presented at ATS
  • Press Releases

GSK advances the future of respiratory medicine and patient care with new data presented at ATS

  • The Pharma Data
  • May 3, 2025

GSK to Present 43 Abstracts Across Respiratory Portfolio at ATS 2025, Including New Data on Mepolizumab and Depemokimab GSK plc (LSE/NYSE: GSK) today announced that 43 abstracts, including four late-breaking…

Read MoreGSK advances the future of respiratory medicine and patient care with new data presented at ATS
  • Business

Sanofi Highlights Scientific Leadership and Innovation in Chronic Inflammatory Respiratory Diseases at ATS

  • The Pharma Data
  • May 2, 2025

Sanofi Showcases Expansive Respiratory Innovation and Scientific Leadership at ATS 2025 with Robust Clinical Data from Dupixent and Immunology Pipeline Sanofi is poised to make a major impact at the…

Read MoreSanofi Highlights Scientific Leadership and Innovation in Chronic Inflammatory Respiratory Diseases at ATS
  • Press Releases

Amgen Announces First Quarter 2025 Financial Performance

  • The Pharma Data
  • May 2, 2025

Amgen Posts Strong First Quarter 2025 Financial Results, Driven by Robust Product Demand and Strategic Launches Amgen Inc. (NASDAQ: AMGN) reported its financial results for the first quarter of 2025,…

Read MoreAmgen Announces First Quarter 2025 Financial Performance
  • Research

Breztri Achieves Primary Endpoints in Pivotal Phase III KALOS and LOGOS Trials for Asthma

  • The Pharma Data
  • May 2, 2025

AstraZeneca’s Breztri Achieves Primary Endpoints in KALOS and LOGOS Phase III Trials, Marking a Significant Advance in the Treatment of Uncontrolled Asthma AstraZeneca announced encouraging high-level results from its pivotal…

Read MoreBreztri Achieves Primary Endpoints in Pivotal Phase III KALOS and LOGOS Trials for Asthma
  • NewsPress Releases

BOTOX® Cosmetic Advances Its Commitment to Entrepreneurial Empowerment with “The Confidence Project”

  • The Pharma Data
  • May 2, 2025

BOTOX® Cosmetic Expands Commitment to Female Empowerment with The Confidence Project for Women Entrepreneurs In a bold move to champion female entrepreneurship and narrow the persistent confidence gap between men…

Read MoreBOTOX® Cosmetic Advances Its Commitment to Entrepreneurial Empowerment with “The Confidence Project”
  • News

Eli Lilly Unveils Q1 2025 Financial Results, Showcases Strong Pipeline Progress

  • The Pharma Data
  • May 2, 2025

Eli Lilly Reports Strong Q1 2025 Financial Results, Driven by Surging Demand for Mounjaro and Zepbound, While Advancing Pipeline Innovations Eli Lilly and Company (NYSE: LLY) has delivered a robust…

Read MoreEli Lilly Unveils Q1 2025 Financial Results, Showcases Strong Pipeline Progress
Vaccine
  • Research

Vaccine Study Shows Fewer Side Effects with PharmaJet Needle-Free Delivery

  • The Pharma Data
  • May 2, 2025

Vaccine Study Shows Fewer Side Effects with PharmaJet Needle-Free Delivery PharmaJet®, a company committed to advancing the performance, safety, and effectiveness of injectable vaccines and therapies through innovative needle-free injection…

Read MoreVaccine Study Shows Fewer Side Effects with PharmaJet Needle-Free Delivery
HSS
  • Research

AI-Driven HSS Study Identifies Risk Factors for Severe Pain After Knee Replacement

  • The Pharma Data
  • May 2, 2025

AI-Driven HSS Study Identifies Risk Factors for Severe Pain After Knee Replacement At the 50th Annual Meeting of the American Society of Regional Anesthesia and Pain Medicine (ASRA), a groundbreaking…

Read MoreAI-Driven HSS Study Identifies Risk Factors for Severe Pain After Knee Replacement
PrevNext
UK Biotech Day
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany
Global Clinical

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • Armatus Unveils Breakthrough Data Advancing TVR110 MicroRNA Therapy for Charcot-Marie-Tooth Disease Type 1A
  • Clarametyx Biosciences Bolsters Executive Team to Drive Clinical Development Progress
  • Coya Therapeutics Unveils Board Transition Plan, Appoints Mark H. Pavao as Independent Director
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.